Drugs / Silver nanoparticles
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01243320 | Dec 2010 → Jul 2011 | — | University of Utah | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT04978025 | Nov 2020 → Nov 2021 | severe acute respiratory syndrome | Hôpital Universitaire Sahloul | Unknown | No outcome recorded |
| — | NCT05231330 | Mar → Oct 2020 | dental caries | Suez Canal University | Completed | No outcome recorded |
| Comparator or background therapy4 trials | ||||||
| Phase 1 | NCT03752424 Comparator | Nov 2019 → Jan 2020 | bacterial infectious disease, tinea pedis | Al-Azhar University | Unknown | No outcome recorded |
| Phase 3 | NCT06963788 Comparator | Feb → Apr 2024 | — | Can Tho University of Medicine and Pharmacy | Completed | No outcome recorded |
| Phase 4 | NCT03692286 Comparator | Jun 2019 → Aug 2020 | — | Cairo University | Completed | No outcome recorded |
| — | NCT06771570 Comparator | Aug 2022 → Aug 2024 | dental pulp necrosis | Radwa fath Ahmed | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Silver nanoparticles | “Silver Nanoparticles in gel form” NCT03692286 ↗ |
| Known as | Colloidal Silver | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04978025 ↗ |
| Action | Inhibit | “obtain a significant inhibition of the bacterial strains” NCT03752424 ↗ |
| Route | Oral | “Oral Dose of 10ppm” NCT01243320 ↗ |